Cargando…

Intrahepatic Cholangiocarcinoma Cells Promote Epithelial-mesenchymal Transition of Hepatocellular Carcinoma Cells by Secreting LAMC2

Hepatocellular carcinoma and intrahepatic cholangiocarcinoma cells are common primary hepatic tumor cells in the liver. Combined hepatocellular cholangiocarcinoma (CHC) contains both hepatocellular carcinoma cells and intrahepatic cholangiocarcinoma cells in one tumor lesion and these tumors show po...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cen, Wenda, Li, Jiandong, Tong, Chenhao, Zhang, Weiguang, Zhao, Yunfeng, Lu, Baochun, Yu, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120174/ https://www.ncbi.nlm.nih.gov/pubmed/33995623 http://dx.doi.org/10.7150/jca.55627

Ejemplares similares

Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis
por: Li, Jiandong, et al.
Publicado: (2022)

Silencing ARAF Suppresses the Malignant Phenotypes of Gallbladder Cancer Cells
por: Lin, Weiguo, et al.
Publicado: (2020)

Pterostilbene inhibits gallbladder cancer progression by suppressing the PI3K/Akt pathway
por: Tong, Chenhao, et al.
Publicado: (2021)

Inhibition of heat shock protein 90 alleviates cholestatic liver injury by decreasing IL-1β and IL-18 expression
por: Tong, Chenhao, et al.
Publicado: (2021)

LAMC2 is a potential prognostic biomarker for cholangiocarcinoma
por: Ong, Khaa Hoo, et al.
Publicado: (2023)

Comprehensive Multiple Molecular Profile of Epithelial Mesenchymal Transition in Intrahepatic Cholangiocarcinoma Patients
por: Huang, Xiao-Yong, et al.
Publicado: (2014)

Periostin promotes malignant potential by induction of epithelial‐mesenchymal transition in intrahepatic cholangiocarcinoma
por: Mino, Masaaki, et al.
Publicado: (2017)

Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma
por: Yao, Xing, et al.
Publicado: (2012)

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Massarweh, Nader N., et al.
Publicado: (2017)

A novel nomogram for the prediction of intrahepatic cholangiocarcinoma in patients with intrahepatic lithiasis complicated by imagiologically diagnosed mass
por: Chen, Gang, et al.
Publicado: (2018)

Metformin exerts anti-cancerogenic effects and reverses epithelial-to-mesenchymal transition trait in primary human intrahepatic cholangiocarcinoma cells
por: Di Matteo, Sabina, et al.
Publicado: (2021)

Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular‐cholangiocarcinoma after resection
por: Song, Peipei, et al.
Publicado: (2019)

Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma
por: Auer, Timo Alexander, et al.
Publicado: (2023)

Mesenchymal stem cells promote chemoresistance by activating autophagy in intrahepatic cholangiocarcinoma
por: Gan, Linhe, et al.
Publicado: (2021)

Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis
por: Jin, Jinglan, et al.
Publicado: (2020)

Geographic Variation of Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, and Hepatocellular Carcinoma in the United States
por: Altekruse, Sean F., et al.
Publicado: (2015)

MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
por: Sammon, Jennifer, et al.
Publicado: (2018)

Lysyl oxidase induces epithelial‐mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma
por: Umezaki, Naoki, et al.
Publicado: (2019)

Staging and Prognostic Models for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Burkhart, Richard A., et al.
Publicado: (2017)

Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Kis, Bela, et al.
Publicado: (2017)

Proteome Landscapes of Human Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Yi, Xiao, et al.
Publicado: (2023)

Gut dysbiosis in Thai intrahepatic cholangiocarcinoma and hepatocellular carcinoma
por: Pomyen, Yotsawat, et al.
Publicado: (2023)

Overexpression of long non-coding RNA CRNDE facilitates epithelial-mesenchymal transition and correlates with poor prognosis in intrahepatic cholangiocarcinoma
por: Xia, Xiu-Liang, et al.
Publicado: (2018)

MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression
por: Zu, Chao, et al.
Publicado: (2017)

ACOT12-mediated acetyl-CoA hydrolysis suppresses intrahepatic cholangiocarcinoma metastasis by inhibiting epithelial-mesenchymal transition
por: Zhou, Xu, et al.
Publicado: (2022)

Hepatitis B virus-associated intrahepatic cholangiocarcinoma: a malignancy of distinctive characteristics between hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Jeong, Seogsong, et al.
Publicado: (2016)

Interleukin-6 induces epithelial-mesenchymal transition in human intrahepatic biliary epithelial cells
por: JIANG, GUI-XING, et al.
Publicado: (2016)

Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma
por: Wang, Tao, et al.
Publicado: (2020)

SQSTM1/p62 in intrahepatic cholangiocarcinoma promotes tumor progression via epithelial–mesenchymal transition and mitochondrial function maintenance
por: Chen, Jiafeng, et al.
Publicado: (2022)

Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Venkat, Puja S., et al.
Publicado: (2017)

Classification of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma Based on Radiomic Analysis
por: Xu, Xiaoliang, et al.
Publicado: (2022)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma
por: Zhang, Yaojun, et al.
Publicado: (2017)

AZGP1 activation by lenvatinib suppresses intrahepatic cholangiocarcinoma epithelial-mesenchymal transition through the TGF-β1/Smad3 pathway
por: Deng, Liming, et al.
Publicado: (2023)

Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Yang, Jie, et al.
Publicado: (2020)

Propensity-matched analysis of patients with intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma and hepatocellular carcinoma undergoing a liver transplant
por: Brandão, Ajacio Bandeira de Mello, et al.
Publicado: (2022)

Epithelial–Mesenchymal Transition in Liver Fluke-Induced Cholangiocarcinoma
por: Sawanyawisuth, Kanlayanee, et al.
Publicado: (2021)

Prognostic values of tissue-resident CD8(+)T cells in human hepatocellular carcinoma and intrahepatic cholangiocarcinoma
por: Chen, Lujun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_iis679gca5og6u7gnjsi9gk516